Nvidia's China Comeback Finally Begins — But Here's Why Investors Should Keep Expectations in Check

Nvidia’s H200 AI accelerator shipments to China have resumed after receiving U.S. approval, but only a limited number have shipped so far, per a Commerce official testimony to Congress. China was previously ~20% of Nvidia revenue and ~95% of the advanced accelerator market before the 2022 export restrictions, and while domestic competitors (e.g., Huawei) have gained share, Chinese cloud buyers and firms like Alibaba and JD.com are still pursuing H200 purchases. The incremental China demand is modest rather than a full reopening, but it reduces a key overhang and supports the bull case as global hyperscaler capex remains the primary growth engine.

Analysis

The market should treat this as a valuation-supporting de-risking event for NVDA more than a near-term earnings inflection. With China reopening only in a metered way, the revenue delta is likely modest versus the company’s overall AI capex engine, but the bigger mechanism is that it removes a residual zero-China tail risk and reinforces that the core product stack still sets the benchmark even under export controls. That matters for multiples: a small amount of incremental China optionality can still support a higher duration narrative if hyperscaler demand remains intact.

Competitively, the limited restart is less bullish for China’s domestic accelerator ecosystem than it is for NVDA’s moat. Controlled access keeps local buyers dependent on the foreign reference architecture while giving domestic rivals time but not a clean substitution win. AMD gets some halo benefit from broader approvals, but the market should not extrapolate equal share capture: shipment caps and software ecosystem lock-in likely make this more of an option value story than a meaningful mix shift.

The contrarian miss is that this is not a broad reopening of the Chinese AI market; it is a scarce, policy-constrained channel. If shipment volumes stay token, the move can fade quickly, and the stock will still trade primarily on Blackwell ramp, hyperscaler capex, and gross-margin durability. Over 1-3 months, the key catalyst is whether licensing broadens or remains a political valve; over 6-18 months, the real risk is China accelerating domestic substitution enough to cap the long-run addressable market. Falsify the bullish read if China commentary in the next two quarters shows no revenue lift and no easing of restrictions beyond H200-class product.

Key Decisions for Investors

• Maintain or add to NVDA on weakness only; this is a sentiment/multiple tailwind, not a thesis-changing EPS event. Best expressed via 1-3 month call spreads rather than outright chasing the open, since the fundamental uplift is likely low-single-digit.
• Pair trade: long NVDA / short AMD over the next 1-3 months. If China access broadens incrementally, NVDA should capture the stronger multiple response because its ecosystem lock-in and pricing power are more durable; AMD’s China optionality is more easily commoditized.
• Watch BABA and JD as secondary beneficiaries, but treat any rally as capex-efficiency rather than demand acceleration. Only get constructive if management commentary confirms AI spend is rising rather than just being re-routed from domestic chips.
• Set a catalyst alert for any policy expansion beyond H200-class shipments. If approvals widen to newer architectures, re-rate the whole semi complex higher; if licensing pauses or reverses, expect the China optionality premium in NVDA to mean-revert quickly.
• If NVDA trades up >3-5% on this headline without a corresponding guide-up next quarter, fade part of the move via short-dated calls against stock or trim some exposure; the market may be overpricing the revenue contribution relative to the actual shipment cap.